Corciulo, Carmen
Castro, Cristina M.
Coughlin, Thomas
Jacob, Samson
Li, Zhu
Fenyƶ, David
Rifkin, Daniel B.
Kennedy, Oran D.
Cronstein, Bruce Neil
Funding for this research was provided by:
Arthritis Foundation
NYU School of Medicine Applied Research Support Fund
NIH (R01 AR068593)
NYU-HHC Clinical and Translational Science Institute (UL1 TR000038)
Translational Research Laboratory Instruments at NYU-Langone Health
Article History
Received: 8 December 2019
Accepted: 12 June 2020
First Online: 10 August 2020
Competing interests
: C Corciulo and BN Cronstein have a patent for the methods and compositions for treating osteoarthritis and promoting cartilage formation (US Patent 10,441,541) which has been assigned to NYU School of Medicine, and they are co-founders of Regenosine Inc. BN Cronstein has consulted for Eli Lilly & Co., Horizon Pharmaceuticals and AstraZeneca and has a grant from AstraZeneca. DB Rifkin consults for Schoar Rock and Blade Pharmaceuticals. C Castro, T Coughlin, S Jacob, D Fenyƶ, OD Kennedy declare no competing financial interests.